TGF-β is also a well-known immunosuppressive factor, and in a 2004 trial in Oregon, the level of TGF-β was also higher in HNSCC tumors from 32 patients with sleep apnea than in five normal oropharyngeal tissues (42). Here, TGFB1 is linked to sleep apnea syndrome.